Amgen Inc. buy BMO Capital Markets
Start price
03.05.24
/
50%
€292.50
Target price
03.05.25
€329.44
Performance (%)
-2.95%
Price
31.05.24
€281.80
Summary
This prediction is currently active. With a performance of -2.95%, the BUY prediction by BMO_Capital_Markets is trending in the wrong direction. Dividends of €2.07 are taken into consideration when calculating the performance. This prediction currently runs until 03.05.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Amgen Inc. | -0.035% |
iShares Core DAX® | -0.552% |
iShares Nasdaq 100 | -1.415% |
iShares Nikkei 225® | -0.877% |
iShares S&P 500 | -0.415% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at BMO Capital Markets from $336.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat